14/11/2017 - 09:20 StockMarketWire
Liberum Capital today upgrades its investment rating on Shire PLC (LON:SHP) to buy (from hold) and left its price target...
CHMP recommends EU marketing authorization for ADYNOVI® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A
13/11/2017 - 06:00 RNS
Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and Oncology
10/11/2017 - 12:00 RNS
06/11/2017 - 09:20 StockMarketWire
Berenberg today reaffirms its buy investment rating on Shire PLC (LON:SHP) and raised its price target to 6000p (from 59...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment